Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis.

Saetrom P, Biesinger J, Li SM, Smith D, Thomas LF, Majzoub K, Rivas GE, Alluin J, Rossi JJ, Krontiris TG, Weitzel J, Daly MB, Benson AB, Kirkwood JM, O'Dwyer PJ, Sutphen R, Stewart JA, Johnson D, Larson GP.

Cancer Res. 2009 Sep 15;69(18):7459-65. doi: 10.1158/0008-5472.CAN-09-1201. Epub 2009 Sep 8.

2.

BMPR1B up-regulation via a miRNA binding site variation defines endometriosis susceptibility and CA125 levels.

Chang CY, Chen Y, Lai MT, Chang HW, Cheng J, Chan C, Chen CM, Lee SC, Lin YJ, Wan L, Tsai PW, Yang SH, Chung C, Sheu JJ, Tsai FJ.

PLoS One. 2013 Dec 5;8(12):e80630. doi: 10.1371/journal.pone.0080630. eCollection 2013.

3.

A miR-125b binding site polymorphism in bone morphogenetic protein membrane receptor type IB gene and prostate cancer risk in China.

Feng N, Xu B, Tao J, Li P, Cheng G, Min Z, Mi Y, Wang M, Tong N, Tang J, Zhang Z, Wu H, Zhang W, Wang Z, Hua L.

Mol Biol Rep. 2012 Jan;39(1):369-73. doi: 10.1007/s11033-011-0747-9. Epub 2011 May 10.

PMID:
21556765
4.

MiR-125b Regulates the Osteogenic Differentiation of Human Mesenchymal Stem Cells by Targeting BMPR1b.

Wang H, Xie Z, Hou T, Li Z, Huang K, Gong J, Zhou W, Tang K, Xu J, Dong S.

Cell Physiol Biochem. 2017;41(2):530-542. doi: 10.1159/000457013. Epub 2017 Jan 31.

5.

Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.

Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, Manoukian S, Secreto G, Ravagnani F, Wang X, Radice P, Croce CM, Davuluri RV, Calin GA.

Cancer Res. 2010 Apr 1;70(7):2789-98. doi: 10.1158/0008-5472.CAN-09-3541. Epub 2010 Mar 23.

6.

Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer.

Bagheri F, Mesrian Tanha H, Mojtabavi Naeini M, Ghaedi K, Azadeh M.

Mol Med Rep. 2016 May;13(5):4494-8. doi: 10.3892/mmr.2016.5078. Epub 2016 Mar 31.

PMID:
27035115
7.

miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.

Feliciano A, Castellvi J, Artero-Castro A, Leal JA, Romagosa C, Hernández-Losa J, Peg V, Fabra A, Vidal F, Kondoh H, Ramón Y Cajal S, Lleonart ME.

PLoS One. 2013 Oct 3;8(10):e76247. doi: 10.1371/journal.pone.0076247. eCollection 2013.

8.

Involvement of IGF-1R regulation by miR-515-5p modifies breast cancer risk among BRCA1 carriers.

Gilam A, Edry L, Mamluk-Morag E, Bar-Ilan D, Avivi C, Golan D, Laitman Y, Barshack I, Friedman E, Shomron N.

Breast Cancer Res Treat. 2013 Apr;138(3):753-60. doi: 10.1007/s10549-013-2502-5. Epub 2013 Apr 3.

PMID:
23549953
9.

G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer.

Li Y, Nie Y, Cao J, Tu S, Lin Y, Du Y, Li Y.

Mol Carcinog. 2014 Mar;53(3):219-29. doi: 10.1002/mc.21966. Epub 2012 Oct 12.

PMID:
23065816
10.

miR-485-5p binding site SNP rs8752 in HPGD gene is associated with breast cancer risk.

He N, Zheng H, Li P, Zhao Y, Zhang W, Song F, Chen K.

PLoS One. 2014 Jul 8;9(7):e102093. doi: 10.1371/journal.pone.0102093. eCollection 2014.

11.

miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression.

Ferracin M, Bassi C, Pedriali M, Pagotto S, D'Abundo L, Zagatti B, Corrà F, Musa G, Callegari E, Lupini L, Volpato S, Querzoli P, Negrini M.

Mol Cancer. 2013 Oct 28;12(1):130. doi: 10.1186/1476-4598-12-130.

12.

The carboxy-terminal domain of connexin 43 (CT-Cx43) modulates the expression of p53 by altering miR-125b expression in low-grade human breast cancers.

Maqbool R, Rashid R, Ismail R, Niaz S, Chowdri NA, Hussain MU.

Cell Oncol (Dordr). 2015 Dec;38(6):443-51. doi: 10.1007/s13402-015-0240-x. Epub 2015 Sep 3.

PMID:
26335100
13.

A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis.

Chu HW, Cheng CW, Chou WC, Hu LY, Wang HW, Hsiung CN, Hsu HM, Wu PE, Hou MF, Shen CY, Yu JC.

Hum Mol Genet. 2014 Jan 15;23(2):355-67. doi: 10.1093/hmg/ddt426. Epub 2013 Sep 5.

PMID:
24009311
14.

MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells.

Zhao Y, Li Y, Lou G, Zhao L, Xu Z, Zhang Y, He F.

PLoS One. 2012;7(6):e39102. doi: 10.1371/journal.pone.0039102. Epub 2012 Jun 18.

15.

An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset.

Song F, Zheng H, Liu B, Wei S, Dai H, Zhang L, Calin GA, Hao X, Wei Q, Zhang W, Chen K.

Clin Cancer Res. 2009 Oct 1;15(19):6292-300. doi: 10.1158/1078-0432.CCR-09-0826. Epub 2009 Sep 29.

16.

The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.

Xie X, Hu Y, Xu L, Fu Y, Tu J, Zhao H, Zhang S, Hong R, Gu X.

Tumour Biol. 2015 Sep;36(9):7185-94. doi: 10.1007/s13277-015-3438-7. Epub 2015 Apr 17.

PMID:
25894378
17.

microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis.

Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, Zhang Y, Paranjape T, Zhu Y.

Cancer Res. 2009 Jul 15;69(14):5970-7. doi: 10.1158/0008-5472.CAN-09-0236. Epub 2009 Jun 30. Erratum in: Cancer Res. 2009 Aug 15;69(16):6758.

18.

Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.

Lin Y, Nie Y, Zhao J, Chen X, Ye M, Li Y, Du Y, Cao J, Shen B, Li Y.

Carcinogenesis. 2012 Dec;33(12):2377-83. doi: 10.1093/carcin/bgs292. Epub 2012 Sep 12.

PMID:
22971574
19.

Evaluation the susceptibility of five polymorphisms in microRNA-binding sites to female breast cancer risk in Chinese population.

He BS, Pan YQ, Lin K, Ying HQ, Wang F, Deng QW, Sun HL, Gao TY, Wang SK.

Gene. 2015 Nov 15;573(1):160-5. doi: 10.1016/j.gene.2015.07.052. Epub 2015 Jul 16.

PMID:
26190157
20.

MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.

Cheng CW, Wang HW, Chang CW, Chu HW, Chen CY, Yu JC, Chao JI, Liu HF, Ding SL, Shen CY.

Breast Cancer Res Treat. 2012 Aug;134(3):1081-93. doi: 10.1007/s10549-012-2034-4. Epub 2012 Apr 4.

PMID:
22476851

Supplemental Content

Support Center